Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, sparking a warning from experts to get regular GP check-ups.
Patients on GLP-1 agonists Wegovy and Ozempic reported flu-like symptoms, fatigue, abdominal cramps and vomiting, thought to be related to liver injury.
The most severe cases were rushed to hospital after experiencing symptoms associated with inflammation of the liver.
The Therapeutic Goods Administration (TGA) has received three separate reports of hepatitis or liver injury associated with semaglutide medicine use – marketed as Ozempic and Wegovy.
Two patients were on Ozempic while the other was using Wegovy.
Patients on Mounjaro have also expressed concerns online.
‘Any of you on Mounjaro have had to stop taking it due to it affecting your liver? I’m currently in hospital with medication induced hepatitis and they’re positive it’s from the Mounjaro,’ one woman wrote.
Another commented: ‘Wegovy badly affected my liver and I had to stop, fortunately I didn’t end up in hospital’.
Hellbound and Down 